D-498-2013 Class III Terminated
FDA drug recall D-498-2013 was initiated by Aurobindo Pharma USA Inc on Apr 9, 2013 and is designated Class III. Reason for recall: Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label The recall status is terminated (terminated Jan 23, 2014). Affected quantity: 1776 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 5, 2013
- Initiation Date
- Apr 9, 2013
- Termination Date
- Jan 23, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1776 bottles
Product description
Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India
Reason for recall
Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label
Distribution pattern
Nationwide
Code information
Lot KP3012001-A Exp.12/13 Lot KP3012002-A Exp.12/13
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-498-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026